{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:32:09Z","timestamp":1790087529493,"version":"4.0.1"},"reference-count":59,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinicalnutritionjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.clnu.2024.09.036","type":"journal-article","created":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T06:25:06Z","timestamp":1727245506000},"page":"156-163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["The impact of a whole foods dietary intervention on gastrointestinal symptoms, inflammation, and fecal microbiota in pediatric patients with cystic fibrosis: A pilot study"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0371-0986","authenticated-orcid":false,"given":"Nicole","family":"Green","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carson","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Suskind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marshall","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Pope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hillary","family":"Hayden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"McNamara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kanter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Nay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Rosenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.clnu.2024.09.036_bib1","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1007\/s10620-015-3546-7","article-title":"Gastrointestinal manifestations of cystic fibrosis","volume":"60","author":"Kelly","year":"2015","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clnu.2024.09.036_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174463","article-title":"Abdominal symptoms in cystic fibrosis and their relation to genotype, history, clinical and laboratory findings","volume":"12","author":"Tabori","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.clnu.2024.09.036_bib3","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/thoraxjnl-2017-210473","article-title":"The top 10 research priorities in cystic fibrosis developed by a partnership between people with CF and healthcare providers","volume":"73","author":"Rowbotham","year":"2018","journal-title":"Thorax"},{"key":"10.1016\/j.clnu.2024.09.036_bib4","first-page":"S1569","article-title":"Obesity in Cystic fibrosis: prevalence, trends and associated factors data from the US cystic fibrosis foundation patient registry","author":"Szentpetery","year":"2022","journal-title":"J\u00a0Cyst Fibros"},{"issue":"0","key":"10.1016\/j.clnu.2024.09.036_bib5","article-title":"Nutritional considerations for a new era: a CF foundation position paper","volume":"0","author":"Leonard","year":"2023","journal-title":"J\u00a0Cyst Fibros"},{"issue":"9","key":"10.1016\/j.clnu.2024.09.036_bib6","first-page":"560","article-title":"Gut bacteria in health and disease","volume":"9","author":"Quigley","year":"2013","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.clnu.2024.09.036_bib7","article-title":"The role of the gut microbiome in systemic inflammatory disease","volume":"360","author":"Clemente","year":"2018","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.clnu.2024.09.036_bib8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/MOG.0b013e32835a3493","article-title":"The colonic microbiota in health and disease","volume":"29","author":"Shanahan","year":"2013","journal-title":"Curr Opin Gastroenterol"},{"issue":"1","key":"10.1016\/j.clnu.2024.09.036_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12328-017-0813-5","article-title":"Gut microbiota in the pathogenesis of inflammatory bowel disease","volume":"11","author":"Nishida","year":"2018","journal-title":"Clin J Gastroenterol"},{"issue":"22","key":"10.1016\/j.clnu.2024.09.036_bib10","doi-asserted-by":"crossref","first-page":"8015","DOI":"10.1128\/AEM.05933-11","article-title":"Cross-sectional and longitudinal comparisons of the predominant fecal microbiota compositions of a group of pediatric patients with cystic fibrosis and their healthy siblings","volume":"77","author":"Duytschaever","year":"2011","journal-title":"Appl Environ Microbiol"},{"issue":"5","key":"10.1016\/j.clnu.2024.09.036_bib11","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.jcf.2012.03.007","article-title":"Gut dysbiosis in cystic fibrosis","volume":"11","author":"Scanlan","year":"2012","journal-title":"J\u00a0Cyst Fibros"},{"issue":"4","key":"10.1016\/j.clnu.2024.09.036_bib12","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.clnu.2014.04.004","article-title":"The clinical significance of the gut microbiota in cystic fibrosis and the potential for dietary therapies","volume":"33","author":"Li","year":"2014","journal-title":"Clin Nutr"},{"issue":"1","key":"10.1016\/j.clnu.2024.09.036_bib13","doi-asserted-by":"crossref","first-page":"22493","DOI":"10.1038\/srep22493","article-title":"Metagenomic evidence for taxonomic dysbiosis and functional imbalance in the gastrointestinal tracts of children with cystic fibrosis","volume":"6","author":"Manor","year":"2016","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.clnu.2024.09.036_bib14","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jcf.2020.04.007","article-title":"Development of the gut microbiota in early life: the impact of cystic fibrosis and antibiotic treatment","volume":"19","author":"Kristensen","year":"2020","journal-title":"J\u00a0Cyst Fibros"},{"issue":"2","key":"10.1016\/j.clnu.2024.09.036_bib15","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41591-019-0714-x","article-title":"Fecal dysbiosis in infants with cystic fibrosis is associated with early linear growth failure","volume":"26","author":"Hayden","year":"2020","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.clnu.2024.09.036_bib16","doi-asserted-by":"crossref","first-page":"18593","DOI":"10.1038\/s41598-019-55028-7","article-title":"Gut microbiota in children with cystic fibrosis: a taxonomic and functional dysbiosis","volume":"9","author":"Coffey","year":"2019","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.clnu.2024.09.036_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0208171","article-title":"Gut microbiota signatures in cystic fibrosis: loss of host CFTR function drives the microbiota enterophenotype","volume":"13","author":"Vernocchi","year":"2018","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.clnu.2024.09.036_bib18","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/cid\/cit715","article-title":"Escherichia coli dysbiosis correlates with gastrointestinal dysfunction in children with cystic fibrosis","volume":"58","author":"Hoffman","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.clnu.2024.09.036_bib19","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jcf.2012.10.003","article-title":"Dysbiosis of bifidobacteria and Clostridium cluster XIVa in the cystic fibrosis fecal microbiota","volume":"12","author":"Duytschaever","year":"2013","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.clnu.2024.09.036_bib20","doi-asserted-by":"crossref","first-page":"24857","DOI":"10.1038\/srep24857","article-title":"Disrupted progression of the intestinal microbiota with age in children with cystic fibrosis","volume":"6","author":"Nielsen","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.clnu.2024.09.036_bib21","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.clnesp.2023.04.008","article-title":"Profile of the intestinal microbiota of patients with cystic fibrosis: a systematic review","volume":"55","author":"de Souza Furtado","year":"2023","journal-title":"Clin Nutr ESPEN."},{"issue":"1","key":"10.1016\/j.clnu.2024.09.036_bib22","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12866-017-0968-8","article-title":"The altered gut microbiota in adults with cystic fibrosis","volume":"17","author":"Burke","year":"2017","journal-title":"BMC Microbiol"},{"issue":"2","key":"10.1016\/j.clnu.2024.09.036_bib23","doi-asserted-by":"crossref","first-page":"fiw230","DOI":"10.1093\/femsec\/fiw230","article-title":"Impact of cystic fibrosis disease on archaea and bacteria composition of gut microbiota","volume":"93","author":"Miragoli","year":"2017","journal-title":"FEMS Microbiol Ecol"},{"issue":"1","key":"10.1016\/j.clnu.2024.09.036_bib24","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/s12866-021-02305-z","article-title":"Infants with cystic fibrosis have altered fecal functional capacities with potential clinical and metabolic consequences","volume":"21","author":"Eng","year":"2021","journal-title":"BMC Microbiol"},{"issue":"5","key":"10.1016\/j.clnu.2024.09.036_bib25","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/codi.16472","article-title":"A\u00a0systematic review of the colorectal microbiome in adult cystic fibrosis patients","volume":"25","author":"Gilbert","year":"2023","journal-title":"Colorectal Dis"},{"issue":"Suppl 2","key":"10.1016\/j.clnu.2024.09.036_bib26","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.jcf.2017.07.014","article-title":"Bacterial overgrowth, dysbiosis, inflammation, and dysmotility in the Cystic Fibrosis intestine","volume":"16","author":"Dorsey","year":"2017","journal-title":"J\u00a0Cyst Fibros"},{"issue":"3","key":"10.1016\/j.clnu.2024.09.036_bib27","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/MPG.0b013e3181d1b013","article-title":"Evidence of intestinal inflammation in patients with cystic fibrosis","volume":"51","author":"Werlin","year":"2010","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"3","key":"10.1016\/j.clnu.2024.09.036_bib28","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrgastro.2015.226","article-title":"Cystic fibrosis from the gastroenterologist's perspective","volume":"13","author":"Ooi","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.clnu.2024.09.036_bib29","first-page":"645","article-title":"Intestinal inflammation in children with cystic fibrosis is associated with Crohn\u2019s-like microbiota Disturbances","volume":"8","author":"Enaud","year":"2019","journal-title":"J\u00a0Clin Med"},{"issue":"1","key":"10.1016\/j.clnu.2024.09.036_bib30","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/microorganisms7010014","article-title":"What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases","volume":"7","author":"Rinninella","year":"2019","journal-title":"Microorganisms"},{"issue":"7695","key":"10.1016\/j.clnu.2024.09.036_bib31","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/nature25973","article-title":"Environment dominates over host genetics in shaping human gut microbiota","volume":"555","author":"Rothschild","year":"2018","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.clnu.2024.09.036_bib32","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/ibd.20968","article-title":"Role of diet in the development of inflammatory bowel disease","volume":"16","author":"Chapman-Kiddell","year":"2010","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"10.1016\/j.clnu.2024.09.036_bib33","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/gutjnl-2012-304119","article-title":"Western diet induces dysbiosis with increased E coli in CEABAC10 mice, alters host barrier function favouring AIEC colonisation","volume":"63","author":"Martinez-Medina","year":"2014","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.clnu.2024.09.036_bib34","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1080\/19490976.2015.1005477","article-title":"Deregulation of intestinal anti-microbial defense by the dietary additive, maltodextrin","volume":"6","author":"Nickerson","year":"2015","journal-title":"Gut Microb"},{"issue":"7541","key":"10.1016\/j.clnu.2024.09.036_bib35","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature14232","article-title":"Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome","volume":"519","author":"Chassaing","year":"2015","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.clnu.2024.09.036_bib36","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/s41575-022-00619-5","article-title":"Dietary management of adults with IBD - the emerging role of dietary therapy","volume":"19","author":"Fitzpatrick","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.clnu.2024.09.036_bib37","doi-asserted-by":"crossref","first-page":"947","DOI":"10.3390\/nu11050947","article-title":"A\u00a0review of dietary therapy for IBD and a vision for the future","volume":"11","author":"Green","year":"2019","journal-title":"Nutrients"},{"issue":"8","key":"10.1016\/j.clnu.2024.09.036_bib38","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1136\/gutjnl-2017-313750","article-title":"The low FODMAP diet: recent advances in understanding its mechanisms and efficacy in IBS","volume":"66","author":"Staudacher","year":"2017","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.clnu.2024.09.036_bib39","doi-asserted-by":"crossref","first-page":"944","DOI":"10.3390\/nu12040944","article-title":"Nutrition, IBD and gut microbiota: a review","volume":"12","author":"Mentella","year":"2020","journal-title":"Nutrients"},{"issue":"12","key":"10.1016\/j.clnu.2024.09.036_bib40","doi-asserted-by":"crossref","first-page":"E3749","DOI":"10.3390\/nu12123749","article-title":"The specific carbohydrate diet and diet modification as induction therapy for pediatric Crohn\u2019s disease: a randomized diet controlled trial","volume":"12","author":"Suskind","year":"2020","journal-title":"Nutrients"},{"issue":"1\u20133","key":"10.1016\/j.clnu.2024.09.036_bib41","first-page":"28","article-title":"NOVA. The star shines bright","volume":"7","author":"Monteiro","year":"2016","journal-title":"World Nutrition"},{"issue":"3","key":"10.1016\/j.clnu.2024.09.036_bib42","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/MPG.0000000000000414","article-title":"PedsQL gastrointestinal symptoms module: feasibility, reliability, and validity","volume":"59","author":"Varni","year":"2014","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"3","key":"10.1016\/j.clnu.2024.09.036_bib44","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/j.1536-4801.1994.tb11298.x","article-title":"The acid steatocrit: a much improved method","volume":"19","author":"Tran","year":"1994","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"5","key":"10.1016\/j.clnu.2024.09.036_bib45","doi-asserted-by":"crossref","first-page":"808","DOI":"10.2144\/04365ST04","article-title":"Improved extraction of PCR-quality community DNA from digesta and fecal samples","volume":"36","author":"Yu","year":"2004","journal-title":"Biotechniques"},{"issue":"8","key":"10.1016\/j.clnu.2024.09.036_bib46","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/s41587-019-0209-9","article-title":"Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2","volume":"37","author":"Bolyen","year":"2019","journal-title":"Nat Biotechnol"},{"issue":"7","key":"10.1016\/j.clnu.2024.09.036_bib47","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nmeth.3869","article-title":"DADA2: high-resolution sample inference from Illumina amplicon data","volume":"13","author":"Callahan","year":"2016","journal-title":"Nat Methods"},{"issue":"1","key":"10.1016\/j.clnu.2024.09.036_bib48","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s40168-018-0470-z","article-title":"Optimizing taxonomic classification of marker-gene amplicon sequences with QIIME 2\u2019s q2-feature-classifier plugin","volume":"6","author":"Bokulich","year":"2018","journal-title":"Microbiome"},{"issue":"2","key":"10.1016\/j.clnu.2024.09.036_bib49","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/wics.147","article-title":"ggplot2","volume":"3","author":"Wickham","year":"2011","journal-title":"WIREs Computational Statistics"},{"issue":"12","key":"10.1016\/j.clnu.2024.09.036_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0225004","article-title":"Assessing gastro-intestinal related quality of life in cystic fibrosis: validation of PedsQL GI in children and their parents","volume":"14","author":"Boon","year":"2019","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.clnu.2024.09.036_bib51","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/jpepsy\/jsv005","article-title":"Interpretability of the PedsQLTM gastrointestinal symptoms scales and gastrointestinal worry scales in pediatric patients with functional and organic gastrointestinal diseases","volume":"40","author":"Varni","year":"2015","journal-title":"J\u00a0Pediatr Psychol"},{"issue":"5","key":"10.1016\/j.clnu.2024.09.036_bib52","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1651-2227.1997.tb08914.x","article-title":"Clinical use of acid steatocrit","volume":"86","author":"Van den Neucker","year":"1997","journal-title":"Acta Paediatr"},{"issue":"18","key":"10.1016\/j.clnu.2024.09.036_bib53","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa1105185","article-title":"A\u00a0CFTR potentiator in patients with cystic fibrosis and the G551D mutation","volume":"365","author":"Ramsey","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"19","key":"10.1016\/j.clnu.2024.09.036_bib54","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.clnu.2024.09.036_bib55","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.jand.2020.03.014","article-title":"Effect of CFTR modulators on anthropometric parameters in individuals with cystic fibrosis: an evidence analysis center systematic review","volume":"121","author":"Bailey","year":"2021","journal-title":"J\u00a0Acad Nutr Diet"},{"issue":"1","key":"10.1016\/j.clnu.2024.09.036_bib56","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jcf.2019.05.015","article-title":"Disease progression in patients with cystic fibrosis treated with ivacaftor: data from national US and UK registries","volume":"19","author":"Volkova","year":"2020","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.clnu.2024.09.036_bib57","article-title":"Obesity in cystic fibrosis","volume":"26","author":"Kutney","year":"2021","journal-title":"J\u00a0Clin Transl Endocrinol"},{"issue":"4","key":"10.1016\/j.clnu.2024.09.036_bib58","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jcf.2020.12.021","article-title":"Designing the GALAXY study: partnering with the cystic fibrosis community to optimize assessment of gastrointestinal symptoms","volume":"20","author":"Freeman","year":"2021","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.clnu.2024.09.036_bib59","doi-asserted-by":"crossref","unstructured":"Nichols DP, Paynter AC, Heltshe SL, et\u00a0al. Clinical effectiveness of elexacaftor\/tezacaftor\/ivacaftor in people with cystic fibrosis: a clinical trial. Am J Respir Crit Care Med. 205(5):529-539. doi:10.1164\/rccm.202108-1986OC.","DOI":"10.1164\/rccm.202108-1986OC"},{"issue":"2","key":"10.1016\/j.clnu.2024.09.036_bib60","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jcf.2022.10.003","article-title":"Elexacaftor\/tezacaftor\/ivacaftor and gastrointestinal outcomes in cystic fibrosis: report of promise-GI","volume":"22","author":"Schwarzenberg","year":"2023","journal-title":"J\u00a0Cyst Fibros"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561424003479?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561424003479?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T15:14:44Z","timestamp":1730474084000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561424003479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":59,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S0261561424003479"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2024.09.036","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of a whole foods dietary intervention on gastrointestinal symptoms, inflammation, and fecal microbiota in pediatric patients with cystic fibrosis: A pilot study","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2024.09.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}